These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 7989476)

  • 1. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism.
    Rosenfield RL; Barnes RB; Ehrmann DA
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1686-92. PubMed ID: 7989476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Source localization of androgen excess in adolescent girls.
    Ibáñez L; Potau N; Zampolli M; Prat N; Gussinyé M; Saenger P; Vicens-Calvet E; Carrascosa A
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1778-84. PubMed ID: 7989484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge.
    Ghai K; Rosenfield RL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1336-40. PubMed ID: 8200935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian steroidogenic responses to gonadotropin-releasing hormone agonist testing with nafarelin in hirsute women with adrenal responses to adrenocorticotropin suggestive of 3 beta-hydroxy-delta 5-steroid dehydrogenase deficiency.
    Barnes RB; Ehrmann DA; Brigell DF; Rosenfield RL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):450-5. PubMed ID: 8381802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
    N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17-hydroxyprogesterone responses to gonadotropin-releasing hormone disclose distinct phenotypes of functional ovarian hyperandrogenism and polycystic ovary syndrome.
    Pasquali R; Patton L; Pocognoli P; Cognigni GE; Gambineri A
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4208-17. PubMed ID: 17785360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism.
    Rosenfield RL; Ehrmann DA; Barnes RB; Sheikh Z
    Ann N Y Acad Sci; 1993 May; 687():162-81. PubMed ID: 8323171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of functional ovarian hyperandrogenism in women with androgen excess.
    Ehrmann DA; Rosenfield RL; Barnes RB; Brigell DF; Sheikh Z
    N Engl J Med; 1992 Jul; 327(3):157-62. PubMed ID: 1319000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome.
    Apter D; Bützow T; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1994 Jul; 79(1):119-25. PubMed ID: 8027216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity.
    Rosenfield RL; Garibaldi LR; Moll GW; Watson AC; Burstein S
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1386-9. PubMed ID: 2946712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males.
    Cuttler L; Rosenfield RL; Ehrmann DA; Kreiter M; Burstein S; Cara JF; Levitsky LL
    J Clin Endocrinol Metab; 1993 Feb; 76(2):362-6. PubMed ID: 8432780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing.
    Ibañez L; Hall JE; Potau N; Carrascosa A; Prat N; Taylor AE
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4103-7. PubMed ID: 8923867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of the human chorionic gonadotrophin test for ovarian hyperandrogenism.
    Levrant SG; Barnes RB; Rosenfield RL
    Hum Reprod; 1997 Jul; 12(7):1416-20. PubMed ID: 9262268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.
    Eagleson CA; Gingrich MB; Pastor CL; Arora TK; Burt CM; Evans WS; Marshall JC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4047-52. PubMed ID: 11095431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonographic appearance of polycystic ovaries is associated with exaggerated ovarian androgen and oestradiol responses to gonadotrophin-releasing hormone agonist in women undergoing assisted reproduction treatment.
    Suikkari AM; MacLachlan V; Montalto J; Calderon I; Healy DL; McLachlan RI
    Hum Reprod; 1995 Mar; 10(3):513-9. PubMed ID: 7782424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
    Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom).
    Conte FA; Grumbach MM; Ito Y; Fisher CR; Simpson ER
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1287-92. PubMed ID: 8200927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism.
    Ibañez L; Potau N; Virdis R; Zampolli M; Terzi C; Gussinyé M; Carrascosa A; Vicens-Calvet E
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1599-603. PubMed ID: 8501168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.
    Liu DM; Torchen LC; Sung Y; Paparodis R; Legro RS; Grebe SK; Singh RJ; Taylor RL; Dunaif A
    Hum Reprod; 2014 Dec; 29(12):2764-72. PubMed ID: 25336708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.